Sue Jean Lin Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

ARQT Quotes by TradingView

Sue Jean Lin is Director of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 26,735 shares of ARQT, which is worth approximately $668,375. The most recent transaction as insider was on Nov 24, 2025, when has been sold 25,272 shares (Common Stock) at a price of $30.78 per share, resulting in proceeds of $777,872. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.7K
0% 3M change
39.78% 12M change
Total Value Held $668,375

SUE-JEAN LIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 24 2025
SELL
Open market or private sale
$777,872 $30.78 p/Share
25,272 Reduced 48.59%
26,735 Common Stock
Nov 24 2025
BUY
Exercise of conversion of derivative security
$203,945 $8.07 p/Share
25,272 Added 32.7%
52,007 Common Stock
Jun 12 2025
BUY
Grant, award, or other acquisition
-
7,609 Added 22.16%
26,735 Common Stock
Jun 14 2024
BUY
Grant, award, or other acquisition
-
10,139 Added 34.65%
19,126 Common Stock
May 31 2023
BUY
Grant, award, or other acquisition
-
4,375 Added 32.74%
8,987 Common Stock
Jun 01 2022
BUY
Grant, award, or other acquisition
-
4,312 Added 48.32%
4,612 Common Stock
SL

Sue Jean Lin

Director
Westlake Village, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT